Helene Lindholm

Lindholm, H., Ejeskär, K., Szekeres, F. (2022). Digitoxin Affects Metabolism, ROS Production and Proliferation in Pancreatic Cancer Cells Differently Depending on the Cell Phenotype International Journal of Molecular Sciences, 23(15), 1-14. More information

Lindholm, H., Ejeskär, K., Szekeres, F. (2022). Na+/K+‑ATPase subunit α3 expression is associated with the efficacy of digitoxin treatment in pancreatic cancer cells Medicine International, 2(5). More information

Lindholm, H. (2023). Repurposing digitoxin in the treatment of pancreatic ductal adenocarcinoma: genotypic and phenotypic features as biomarkers for digitoxin sensitivity in vitro (Doctoral thesis, Jönköping: Jönköping University, School of Health and Welfare). More information

Lindholm, H., Herring, M., Faresjö, M., Haux, J., Szekeres, F., Ejeskär, K. . Inflammasomes can be formed in pancreatic cancer cells, and NLRP3 inflammasome associated genes are up-regulated in primary pancreatic tumors. More information

Lindholm, H., Ulfenborg, B., Faresjö, M., Haux, J., Ejeskär, K., Szekeres, F. . Digitoxin treatment affects choline metabolism in pancreatic cancer cells. More information